Thymosin alpha 1 is a thymus peptide with recognized immune modulating capacity and biochemical properties. Clinical studies have demonstrated the significant role of thymosin alpha 1 in immune and inflammatory responses, and extensive research has shown its effective use in a myriad of diseases ranging from hepatitis and HIV to immune deficiencies and cancers, as well as its use as a vaccine adjuvant.

Thymosin alpha 1: A comprehensive review of the literature